Emvision Medical Devices Ltd has released a press release.
Additional Pivotal Trial Site Activations
Filed with ASX ·
6ix hasn’t read this filing yet.
EMvision Medical Devices Ltd. on 6ix
Earlier from EMvision Medical Devices
- Enhanced Algorithm Performance From Continuous Innovation
- Activation of Second US Pivotal Trial Site, Mayo Clinic
- Emu Pivotal Validation Trial Commences
- First Responder Scanner in Successful Aeromedical Testing
- S&P DJI Announces March 2025 Quarterly Rebalance
Later from EMvision Medical Devices
- EMVision Awarded $5m Non-Dilutive Government Grant
- Key Developments in Pivotal Trial & Innovation Study
- First Responder Program Advanced & Grant Milestone Achieved
- EMVision Awarded $3m Grant For Regional Benefits Study
- UCLA Health Activation & Continuous Innovation Study Update
Follow EMvision Medical Devices into a list and get an email when it puts out news.
Follow EMvision Medical Devices